Kiora Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Kiora Pharmaceuticals's estimated annual revenue is currently $1.4M per year.
- Kiora Pharmaceuticals's estimated revenue per employee is $77,500
Employee Data
- Kiora Pharmaceuticals has 18 Employees.
- Kiora Pharmaceuticals grew their employee count by 6% last year.
Kiora Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | President, CEO and Director | Reveal Email/Phone |
2 | Chief Development Officer | Reveal Email/Phone |
3 | EVP Finance | Reveal Email/Phone |
4 | EVP CMC and Operations | Reveal Email/Phone |
5 | Senior Director, Clinical Development | Reveal Email/Phone |
6 | Associate Director HR / Marketing Communications | Reveal Email/Phone |
7 | Director Drug Manufacturing | Reveal Email/Phone |
8 | Senior Accountant | Reveal Email/Phone |
9 | Controller | Reveal Email/Phone |
Kiora Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Kiora Pharmaceuticals?
Kiora Pharmaceuticals, Inc. (Kiora) is an ophthalmic specialty pharmaceutical company that develops therapies for the treatment of different types of eye diseases. Publicly-traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision.
keywords:N/AN/A
Total Funding
18
Number of Employees
$1.4M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.6M | 18 | 6% | N/A |
#2 | $3.5M | 18 | -31% | N/A |
#3 | $1.7M | 19 | 36% | N/A |
#4 | $1.7M | 19 | -27% | N/A |
#5 | $1.7M | 19 | 12% | N/A |